Swiss Re Ltd. (OTCMKTS:SSREY - Get Free Report) was the target of a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 11,083 shares, a drop of 57.4% from the February 12th total of 25,986 shares. Based on an average daily trading volume, of 84,135 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company's shares are short sold. Currently, 0.0% of the company's shares are short sold. Based on an average daily trading volume, of 84,135 shares, the days-to-cover ratio is currently 0.1 days.
Wall Street Analyst Weigh In
SSREY has been the topic of several research analyst reports. Oddo Bhf cut Swiss Re to a "neutral" rating in a research note on Tuesday, December 9th. UBS Group lowered Swiss Re from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 17th. Citigroup cut shares of Swiss Re from a "buy" rating to a "hold" rating in a report on Tuesday, December 9th. DZ Bank raised shares of Swiss Re from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, December 9th. Finally, Royal Bank Of Canada restated an "underperform" rating on shares of Swiss Re in a report on Monday, December 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Reduce".
Get Our Latest Report on SSREY
Swiss Re Stock Performance
SSREY opened at $41.44 on Wednesday. Swiss Re has a 52 week low of $37.56 and a 52 week high of $48.62. The business has a 50 day moving average of $40.92 and a 200-day moving average of $43.26.
Swiss Re Company Profile
(
Get Free Report)
Swiss Re OTCMKTS: SSREY is a global reinsurance company headquartered in Zurich, Switzerland. Founded in 1863, the firm provides risk transfer and insurance solutions to insurers, reinsurers, and large corporations worldwide. Its core activities encompass reinsurance for property & casualty and life & health lines, as well as tailored corporate insurance products designed to protect complex commercial and industrial risks.
Swiss Re's product offering spans treaty and facultative reinsurance, structured reinsurance solutions, and capital markets–linked risk transfer such as insurance‑linked securities.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Swiss Re, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Swiss Re wasn't on the list.
While Swiss Re currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.